The Human Digitome: a 21st-century ’omics to deliver personalized medicine

Digital trial company Medable has created the first Human Digitome, a digital platform that represents human health and disease and is built to provide real-world data for personalized and predictive medicine

Like Comment
Page of
Go to the profile of Medable


Medable is a privately held, venture-backed company headquartered in Palo Alto, California. Medable is on a mission to get effective therapies to patients faster by dramatically reducing the time from therapeutic development to market realization with digital data capture and real-time analytics that remove the complexities clinical research to dramatically reduce trial timelines. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution. Our platform allows patients, healthcare providers, clinical research organizations and pharmaceutical sponsors to work together as a connected and empowered team in clinical trials.

No comments yet.